A case of familial partial lipodystrophy caused by a novel lamin A/C (LMNA) mutation in exon 1 (D47N)

Eur J Intern Med. 2016 Apr:29:37-9. doi: 10.1016/j.ejim.2015.12.012. Epub 2016 Jan 7.

Abstract

Background: Familial partial lipodystrophy (FPL) is a rare genetic disorder characterized by selective lack of subcutaneous fat which is associated with insulin resistant diabetes. The Dunnigan variety (FPL2) is caused by several missense mutations in the lamin A/C (LMNA) gene, most of which are typically located in exon 8 at the codon position 482.

Case report: Here, we report on a Turkish family with FPL2 which is caused by a novel heterozygous missense LMNA mutation in exon 1 (D47N, c.139G>A), in the rod domain of lamins A/C. Fat distribution and metabolic features of LMNA D47N mutation were similar to typical codon 482 mutation. Metabolic abnormalities were observed as a form of insulin resistant diabetes, hypertriglyceridemia, low HDL cholesterol and hepatic steatosis. There was no evidence for neuromuscular and cardiac involvement.

Conclusion: Although it is previously known that alterations in the rod domain of type A lamins are involved in cardiac and neuromuscular diseases, our current observation shows that exon 1 LMNA mutations may be associated with partial lipodystrophy without any cardiac and neurological abnormalities, at least at the time of the presentation.

Keywords: Diabetes; Insulin resistance; LMNA; Lipodystrophy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Diabetes Mellitus / drug therapy
  • Diabetes Mellitus / genetics
  • Exons
  • Fatty Liver / diagnostic imaging
  • Female
  • Heterozygote
  • Humans
  • Insulin / therapeutic use
  • Insulin Resistance / genetics
  • Lamin Type A / genetics*
  • Lipodystrophy, Familial Partial / drug therapy
  • Lipodystrophy, Familial Partial / genetics*
  • Magnetic Resonance Imaging
  • Metformin / therapeutic use
  • Mutation

Substances

  • Insulin
  • Lamin Type A
  • Metformin